中山市生物医药产业竞争力评价及障碍因素分析
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Competitiveness Evaluation and Obstacle Factors Analysis of Biomedical Industry in Zhongshan City
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    从创新、规模、经营和环境4个准则层构建生物医药产业竞争力评价指标体系,采用熵值法确定指标权重,运用TOPSIS(优劣解距离法)-灰色关联度分析模型对产业竞争力水平进行综合评价,并结合障碍度模型分析阻碍中山市生物医药产业发展的因素。研究发现,2016—2021年中山市生物医药产业竞争力水平总体呈上升趋势,增幅达到62.39%。经营是中山市生物医药产业发展的最大准则层障碍因素。药品注册证数、R&D经费内部支出、工业总产值、利润总额和常住人口人均GDP是主要障碍因素。

    Abstract:

    The evaluation index system of biomedical industry competitiveness was constructed from the four criteria layers of innovation, scale, management and environment, the index weight was determined by entropy method, and the industrial competitiveness level was comprehensively evaluated by TOPSIS (Technique for Order Preference by Similarity to Ideal Solution) -gray relational analysis model, and the factors hindering the development of biomedical industry in Zhongshan were analyzed by combining the obstacle degree model. The results indicate that the competitiveness level of the biomedical industry in Zhongshan City showed an overall upward trend from 2016 to 2021, with an increase of 62.39%. Management is the biggest obstacle factor for the development of biomedical industry in Zhongshan City. The number of drug registration certificates, internal expenditure of R&D funds, gross industrial output value, total profits and GDP per capita of resident population are the main obstacles.

    参考文献
    相似文献
    引证文献
引用本文

岳新燕,阮娴静,徐恩怡,沈曼娜.中山市生物医药产业竞争力评价及障碍因素分析[J].科技与产业,2024,24(12):156-161

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-06-26